Despite the fact that its role in CRC drug resistance/response has not been investigated yet, it has been reported that the overexpression of miR-301a-3p promoted gemcitabine resistance in pancreatic cancer cells, in vitro, by regulating the expression of PTEN [63]. The gene discussed is PTEN; the disease is pancreatic neoplasm.